Cargando…
Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer
We present a study to evaluate the feasibility and clinical utility of amplicon‐based Oncomine Pan‐Cancer cell‐free assay to detect circulating tumor DNA (ctDNA) in patients with early or advanced breast cancer. In this study, 109 early and metastatic breast cancer patients were recruited before the...
Autores principales: | Chin, Yoon Ming, Takahashi, Yoko, Chan, Hiu Ting, Otaki, Masumi, Fujishima, Makoto, Shibayama, Tomoko, Miki, Yoshio, Ueno, Takayuki, Nakamura, Yusuke, Low, Siew‐Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780051/ https://www.ncbi.nlm.nih.gov/pubmed/33075187 http://dx.doi.org/10.1111/cas.14697 |
Ejemplares similares
-
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer
por: Chin, Yoon Ming, et al.
Publicado: (2022) -
Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
por: Chan, Hiu Ting, et al.
Publicado: (2023) -
Proteomic Analysis of Native Hepatocyte Nuclear Factor-4α (HNF4α) Isoforms, Phosphorylation Status, and Interactive Cofactors
por: Daigo, Kenji, et al.
Publicado: (2011) -
Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy
por: Chan, Hiu Ting, et al.
Publicado: (2020) -
Genomotyping of Pseudomonas putida strains using P. putida KT2440-based high-density DNA microarrays: implications for transcriptomics studies
por: Ballerstedt, Hendrik, et al.
Publicado: (2007)